These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 8439637)

  • 1. Early evening nizatidine intake with a meal optimizes the antisecretory effect.
    Duroux P; Emde C; Bauerfeind P; Biollaz J; Armstrong D; Blum AL
    Aliment Pharmacol Ther; 1993 Feb; 7(1):47-54. PubMed ID: 8439637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acid inhibitory characteristics of nizatidine in man: an overview.
    Parente F; Bianchi Porro G
    Scand J Gastroenterol Suppl; 1994; 206():3-7. PubMed ID: 7863250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of effect of nizatidine-induced elevation of gastric pH on the oral bioavailability of dapsone in healthy volunteers.
    Itokazu GS; Fischer JH; Manitpisitkul P; Hariharan R; Danziger LH
    Pharmacotherapy; 2002 Nov; 22(11):1420-5. PubMed ID: 12432968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of nizatidine and ranitidine on 24 hour intragastric pH, pepsin, prostaglandin E2 and serum gastrin concentrations in healthy volunteers.
    Thompson A; Kirdeikis P; Jamali F; Tavernini M; Zuk L; Marriage B; Simpson I; Mahachai V
    J Gastroenterol Hepatol; 1995; 10(5):546-54. PubMed ID: 8963030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Twenty-four-hour control of gastric acidity by twice-daily doses of placebo, nizatidine 150 mg, nizatidine 300 mg, and ranitidine 300 mg.
    Savarino V; Mela GS; Zentilin P; Cutela P; Mele R; Celle G
    J Clin Pharmacol; 1993 Jan; 33(1):70-4. PubMed ID: 8429117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of oral nizatidine on preoperative gastric fluid pH and volume in children.
    Mikawa K; Nishina K; Maekawa N; Takao Y; Obara H
    Br J Anaesth; 1994 Nov; 73(5):600-4. PubMed ID: 7826786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rebound hypersecretion after H2-antagonist withdrawal--a comparative study with nizatidine, ranitidine and famotidine.
    Fullarton GM; Macdonald AM; McColl KE
    Aliment Pharmacol Ther; 1991 Aug; 5(4):391-8. PubMed ID: 1685675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of pH dataloggers for pharmacologic studies.
    Chiverton SG; Burget DW; Hunt RH
    Scand J Gastroenterol; 1989 Oct; 24(8):975-81. PubMed ID: 2512632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circadian differences in pharmacological blockade of meal-stimulated gastric acid secretion.
    Sanders SW; Moore JG; Day GM; Tolman KG
    Aliment Pharmacol Ther; 1992 Apr; 6(2):187-93. PubMed ID: 1600040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Twenty four hour intragastric acidity and plasma gastrin concentration in healthy volunteers taking nizatidine 150 mg, nizatidine 300 mg, ranitidine 300 mg, or placebo at 21:00 h.
    Lanzon-Miller S; Pounder RE; Chronos NA; Raymond F; Hamilton MR; Dalgleish D
    Gut; 1988 Oct; 29(10):1364-9. PubMed ID: 2904394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and pharmacodynamics of oral nizatidine.
    Vargas R; Ryan J; McMahon FG; Regel G; Offen WW; Matsumoto C
    J Clin Pharmacol; 1988 Jan; 28(1):71-5. PubMed ID: 2895125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of the timing of administration of 300 mg ranitidine on 24-hour gastric pH in patients acute duodenal ulcer.
    Cortot A; Guillemot F; Moreau J; Soule JC; Veyrac M; Alberola B; Pappo M
    Aliment Pharmacol Ther; 1992 Aug; 6(4):487-93. PubMed ID: 1420740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the effects of oral nizatidine and ranitidine on gastric volume and pH in patients undergoing gynaecological laparoscopy.
    Popat MT; Dyar OJ; Blogg CE
    Anaesthesia; 1991 Oct; 46(10):816-9. PubMed ID: 1683179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continuous intragastric pH monitoring: a real progress in the assessment of antisecretory drugs.
    Savarino V
    Ital J Gastroenterol; 1990; 22 Suppl 2():20-3. PubMed ID: 1983412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of acid inhibition by either oral high-dose ranitidine or omeprazole.
    Hurlimann S; Abbühl B; Inauen W; Halter F
    Aliment Pharmacol Ther; 1994 Apr; 8(2):193-201. PubMed ID: 8038351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of preoperative oral use of erythromycin and nizatidine on gastric pH and volume.
    Memis D; Turan A; Karamanlioglu B; Guler T; Yurdakoc A; Pamukcu Z; Turan N
    Anaesth Intensive Care; 2002 Aug; 30(4):428-32. PubMed ID: 12180579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the effects of placebo, ranitidine, famotidine and nizatidine on intragastric acidity by means of continuous pH recording.
    Savarino V; Mela GS; Zentilin P; Scalabrini P; Bonifacino G; Gambaro P; Celle G
    Digestion; 1989; 42(1):1-6. PubMed ID: 2568299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of a single oral morning dose of nizatidine and ranitidine on intragastric pH under basal conditions and after pentagastrin stimulation.
    Lazzaroni M; Sangaletti O; Bianchi Porro G
    J Int Med Res; 1992 Nov; 20(6):454-60. PubMed ID: 1286739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statistical interpretation of the antisecretory effect of famotidine measured by intragastric pH-metry.
    Hunyady B; Juricskay I; Nagy L; Garamszegi M; Vincze A; Mózsik G
    Eur J Clin Pharmacol; 1996; 50(6):449-56. PubMed ID: 8858270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of previous administration of nizatidine on the neuromuscular effects of vecuronium and the effect of nizatidine on gastric secretion.
    Wajima Z; Shitara T; Inoue T; Yoshikawa T; Ogawa R
    Anaesth Intensive Care; 2000 Feb; 28(1):46-8. PubMed ID: 10701036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.